For: | Yang HJ, Guo Z, Yang YT, Jiang JH, Qi YP, Li JJ, Li LQ, Xiang BD. Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis. World J Gastroenterol 2016; 22(21): 5088-5095 [PMID: 27275101 DOI: 10.3748/wjg.v22.i21.5088] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i21/5088.htm |
Number | Citing Articles |
1 |
Zhenhao Chen, Guanglei Zhao, Feiyan Chen, Jun Xia, Li Jiang. The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5511-x
|
2 |
Weibin Wang, Fang Wang, Qingqing Chen, Shuyi Ouyang, Yutaro Iwamoto, Xianhua Han, Lanfen Lin, Hongjie Hu, Ruofeng Tong, Yen-Wei Chen. Phase Attention Model for Prediction of Early Recurrence of Hepatocellular Carcinoma With Multi-Phase CT Images and Clinical Data. Frontiers in Radiology 2022; 2 doi: 10.3389/fradi.2022.856460
|
3 |
Ayman Bannaga, Ramesh P Arasaradnam. Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review. World Journal of Gastroenterology 2020; 26(33): 5022-5049 doi: 10.3748/wjg.v26.i33.5022
|
4 |
SooYoon Sung, Seok Hyun Son, Eun Young Park, Chul Seung Kay, Giancarlo Troncone. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy. PLOS ONE 2017; 12(3): e0173955 doi: 10.1371/journal.pone.0173955
|
5 |
Youya Zang, Peiyun Long, Ming Wang, Shan Huang, Chuang Chen. Development and validation of prognostic nomograms in patients with hepatocellular carcinoma: a population-based study. Future Oncology 2021; 17(36): 5053 doi: 10.2217/fon-2020-1065
|
6 |
Mohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review article. Annals of Hepatology 2021; 22: 100249 doi: 10.1016/j.aohep.2020.08.067
|
7 |
Jie Lin, Binbin Xue, Jia Li, Huaqing Xu, Xiaming Huang, Zhichao Yao, Xiang Li, Junhui Xia. Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD. Neurological Sciences 2017; 38(10): 1859 doi: 10.1007/s10072-017-3068-5
|
8 |
Yunjiao Wang, Chuchu Peng, Zhigang Cheng, Ximei Wang, Lei Wu, Jingyi Li, Changsheng Huang, Qulian Guo, Hongwei Cai. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis. International Journal of Surgery 2018; 55: 73 doi: 10.1016/j.ijsu.2018.05.022
|
9 |
Xiaowei Qiu, Haiqing Zhang, Dongxu Li, Jing Wang, Zhigang Jiang, Yuanzhong Zhou, Ping Xu, Jun Zhang, Zhanhui Feng, Changyin Yu, Zucai Xu. Analysis of Clinical Characteristics and Poor Prognostic Predictors in Patients With an Initial Diagnosis of Autoimmune Encephalitis. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01286
|
10 |
So Jeong Yoon, Seung Soo Hong, Kee-Taek Jang, So Kyung Yoon, Hongbeom Kim, Sang Hyun Shin, Jin Seok Heo, Chang Moo Kang, Kyung Sik Kim, Ho Kyoung Hwang, In Woong Han. Predicting lymph node metastasis using preoperative parameters in patients with T1 ampulla of vater cancer. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12311-9
|
11 |
Hao-Jie Yang, Jing-Hang Jiang, Yu-Ting Yang, Xiang-Di Yang, Zhe Guo, Ya-Peng Qi, Feng-Hua Zeng, Ke-Lan Zhang, Neng-Zhi Chen, Bang-De Xiang, Le-Qun Li. Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival. World Journal of Gastroenterology 2016; 22(39): 8798-8805 doi: 10.3748/wjg.v22.i39.8798
|
12 |
João Paulo Maciel Silva, Fabricio Ferreira Coelho, Alex Jones Flores Cassenote, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, José Donizeti de Meira Júnior, Sérgio Carlos Nahas, Paulo Herman. Preoperative inflammatory markers as prognostic predictors after hepatocellular carcinoma resection: data from a western referral center. BMC Surgery 2022; 22(1) doi: 10.1186/s12893-022-01779-6
|
13 |
Yu-Ting Yang, Jing-Hang Jiang, Hao-Jie Yang, Zhi-jun Wu, Ze-Min Xiao, Bang-De Xiang. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20199-2
|
14 |
Hao-Jie Yang, Jing-Hang Jiang, Qing-An Liu, Cheng-Mao Zhou, Yang-feng Du, Tao Wu, Neng-Zhi Chen, Bang-De Xiang. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection. Tumor Biology 2017; 39(6): 101042831770737 doi: 10.1177/1010428317707375
|
15 |
Sheng-chao Li, Zhuo Xu, Yan-li Deng, Ya-ni Wang, Yu-ming Jia. Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma. Medicine 2020; 99(27): e20919 doi: 10.1097/MD.0000000000020919
|
16 |
Weibin WANG, Qingqing CHEN, Yutaro IWAMOTO, Xianhua HAN, Qiaowei ZHANG, Hongjie HU, Lanfen LIN, Yen-Wei CHEN. Deep Learning-Based Radiomics Models for Early Recurrence Prediction of Hepatocellular Carcinoma with Multi-phase CT Images and Clinical Data. 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2019; : 4881 doi: 10.1109/EMBC.2019.8856356
|
17 |
Mathieu Pecqueux, Frederik Brückner, Andreas Bogner, Florian Oehme, Hans‑Michael Hau, Felix von Bechtolsheim, Hanns‑Christoph Held, Franziska Baenke, Marius Distler, Carina Riediger, Jürgen Weitz, Christoph Kahlert. Interleukin-8 is superior to CRP for the prediction of severe complications in a prospective cohort of patients undergoing major liver resection. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-03041-w
|
18 |
Mitsuru Yanagaki, Koichiro Haruki, Tomohiko Taniai, Yosuke Igarashi, Jungo Yasuda, Kenei Furukawa, Shinji Onda, Yoshihiro Shirai, Masashi Tsunematsu, Toru Ikegami. The significance of osteosarcopenia as a predictor of the long‐term outcomes in hepatocellular carcinoma after hepatic resection. Journal of Hepato-Biliary-Pancreatic Sciences 2023; 30(4): 453 doi: 10.1002/jhbp.1246
|
19 |
Qian Zhu, Qiu-Zhong Pan, Ai-Lin Zhong, Hao Hu, Jing-Jing Zhao, Yan Tang, Wan-Ming Hu, Min Li, De-Sheng Weng, Ming-Yuan Chen, Gang Ma, Jian-Chuan Xia. Annexin A3 upregulates the infiltrated neutrophil-lymphocyte ratio to remodel the immune microenvironment in hepatocellular carcinoma. International Immunopharmacology 2020; 89: 107139 doi: 10.1016/j.intimp.2020.107139
|
20 |
Sang Yun Ha, Sangjoon Choi, Sujin Park, Jong Man Kim, Gyu-Seong Choi, Jae-Won Joh, Cheol-Keun Park. Prognostic effect of preoperative neutrophil-lymphocyte ratio is related with tumor necrosis and tumor-infiltrating lymphocytes in hepatocellular carcinoma. Virchows Archiv 2020; 477(6): 807 doi: 10.1007/s00428-020-02841-5
|
21 |
Guang‐Tao Min, Yu‐Min Li, Nan Yao, Jun Wang, Hong‐Peng Wang, Wei Chen. The pretreatment neutrophil‐lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta‐analysis. Clinical Transplantation 2018; 32(1) doi: 10.1111/ctr.13151
|
22 |
Weibin Wang, Fang Wang, Yunjun Yang, Yinhao Li, Jing Liu, Xianhua Han, Lanfen Lin, Ruofeng Tong, Hongjie Hu, Yen-Wei Chen. Deep Learning-based Risk Prediction Model for Recurrence-free Survival in Patients with Hepatocellular Carcinoma Using Multi-phase CT Image. 2022 IEEE 11th Global Conference on Consumer Electronics (GCCE) 2022; : 926 doi: 10.1109/GCCE56475.2022.10014204
|
23 |
Yan Liao, Rongyu Wei, Renzhi Yao, Liling Qin, Jun Li, Junxiong Yu, Weijia Liao. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study. BMC Surgery 2021; 21(1) doi: 10.1186/s12893-020-01037-7
|
24 |
Wei Zhang, Chang Liu, Yifei Tan, Li Jiang, Lunan Yan, Jiayin Yang, Tianfu Wen. Role of liver resection in treating intermediate and advanced stage adolescent and young adult hepatocellular carcinoma patients: A propensity-matching cohort study. International Journal of Surgery 2018; 54: 259 doi: 10.1016/j.ijsu.2018.03.051
|
25 |
Hao-Jie Yang, Jing-Hang Jiang, Yu-Ting Yang, Zhe Guo, Ji-jia Li, Xuan-han Liu, Fei Lu, Feng-Hua Zeng, Jin-Song Ye, Ke-Lan Zhang, Neng-Zhi Chen, Bang-De Xiang, Le-Qun Li. Stratified aspartate aminotransferase-to-platelet ratio index accurately predicts survival in hepatocellular carcinoma patients undergoing curative liver resection. Tumor Biology 2017; 39(3): 101042831769594 doi: 10.1177/1010428317695944
|
26 |
So Jeong Yoon, Hongbeom Kim, Okjoo Lee, Ji Hye Jung, Chang-Sup Lim, Yong Chan Shin, Wooil Kwon, Jin-Young Jang, Sang Hyun Shin, Jin Seok Heo, In Woong Han. Development and external validation of a nomogram with inflammatory markers for predicting invasiveness of intraductal papillary mucinous neoplasm of pancreas. Medicine 2022; 101(11) doi: 10.1097/MD.0000000000029036
|
27 |
Linda Wong, Kliment Bozhilov, Brenda Hernandez, Sandi Kwee, Owen Chan, Luke Ellis, Loic LeMarchand. Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio. Clinical and Molecular Hepatology 2019; 25(3): 305 doi: 10.3350/cmh.2019.0004
|
28 |
Weibin Wang, Qingqing Chen, Yutaro Iwamoto, Panyanat Aonpong, Lanfen Lin, Hongjie Hu, Qiaowei Zhang, Yen-Wei Chen. Deep Fusion Models of Multi-Phase CT and Selected Clinical Data for Preoperative Prediction of Early Recurrence in Hepatocellular Carcinoma. IEEE Access 2020; 8: 139212 doi: 10.1109/ACCESS.2020.3011145
|
29 |
Mitsuru Yanagaki, Koichiro Haruki, Jungo Yasuda, Kenei Furukawa, Shinji Onda, Masashi Tsunematsu, Yoshihiro Shirai, Takeshi Gocho, Tomohiko Taniai, Ryoga Hamura, Toru Ikegami. The Significance of the Rapid Turnover Protein Score as a Predictor of the Long-Term Outcomes in Hepatocellular Carcinoma After Hepatic Resection. Annals of Surgical Oncology 2021; 28(13): 8130 doi: 10.1245/s10434-021-10704-9
|
30 |
Lingling He, Shuan Zhang, Xiaoli Liu, Yuyong Jiang, Xianbo Wang, Zhiyun Yang. HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus. Journal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/3819502
|
31 |
Mitsuru Yanagaki, Yoshihiro Shirai, Ryoga Hamura, Tomohiko Taniai, Yoshiaki Tanji, Koichiro Haruki, Kenei Furukawa, Shinji Onda, Hiroaki Shiba, Toru Ikegami. Novel combined fibrosis-based index predicts the long-term outcomes of hepatocellular carcinoma after hepatic resection. International Journal of Clinical Oncology 2022; 27(4): 717 doi: 10.1007/s10147-021-02111-7
|
32 |
Wei Zhang, Yifei Tan, Shu Shen, Li Jiang, Lunan Yan, Jiayin Yang, Bo Li, Tianfu Wen, Yong Zeng, Wen Tao Wang, Mingqing Xu. Prognostic nomogram for hepatocellular carcinoma in adolescent and young adult patients after hepatectomy. Oncotarget 2017; 8(63): 106393 doi: 10.18632/oncotarget.18192
|
33 |
Xueqin Shen, Wei Wang, Xiaoping Niu. Neutrophil Lymphocyte Ratio to Albumin Ratio and White Blood Cell to Hemoglobin Ratio as Prognostic Markers for Hepatocellular Carcinoma Patients Who Underwent Curative Hepatectomy. International Journal of General Medicine 2021; : 5029 doi: 10.2147/IJGM.S329911
|
34 |
Jia-Xi Mao, Fei Teng, Cong Liu, Hang Yuan, Jia-Yong Dong, Hong Fu, Guo-Shan Ding, Wen-Yuan Guo. Immunometabolic inflammation and hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2019; 18(3): 298 doi: 10.1016/j.hbpd.2019.03.012
|
35 |
Maoting Zhou, Peng Zhang, Qi Mao, Yue Shi, Lin Yang, Xiaoming Zhang. Multisequence MRI-Based Radiomic Features Combined with Inflammatory Indices for Predicting the Overall Survival of HCC Patients After TACE. Journal of Hepatocellular Carcinoma 2024; : 2049 doi: 10.2147/JHC.S481301
|
36 |
Evgenia Kotsifa, Nikolaos Machairas, Apostolos Angelis, Nikolaos I. Nikiteas, Dimitrios Dimitroulis, Georgios C. Sotiropoulos. Decoding the Prognostic Significance and Therapeutic Implications of Inflammation-Based Scores in Hepatocellular Carcinoma: A Comprehensive Review. Cancers 2024; 16(14): 2549 doi: 10.3390/cancers16142549
|